Vaxsafe Mannheimia

GPTKB entity

Properties (45)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:activeDuring Mannheimia_haemolytica_antigens
gptkbp:administrativeDivision annual
injection
gptkbp:category preventive veterinary medicine
gptkbp:clinicalTrials conducted to assess efficacy
gptkbp:communityImpact studies on economic impact of vaccination
gptkbp:contraindication do not use in sick animals
gptkbp:createdCharacter widely used in beef and dairy cattle
gptkbp:diseaseResistance subject to veterinary regulations
surveillance for vaccine-related issues
gptkbp:dosageForm 2 mL
gptkbp:formulation inactivated bacterial vaccine
gptkbp:hasPublications published studies in veterinary journals
https://www.w3.org/2000/01/rdf-schema#label Vaxsafe Mannheimia
gptkbp:mandates for use in at-risk cattle populations
gptkbp:manufacturer Vaxsafe
gptkbp:notable_player requires refrigeration
trained personnel required
bacterial vaccine
ongoing research for improved formulations
high efficacy in preventing disease
cost-effective for herd health
demonstrated effectiveness in field trials
developed based on field strains
distributed through veterinary supply chains
funded by agricultural research grants
monitoring for effectiveness post-vaccination
recommended by veterinary associations
recommended for high-risk herds
reduces incidence of pneumonia in cattle
gptkbp:postRetirementCareer recommended for adverse reactions
gptkbp:regulatoryCompliance approved by veterinary authorities
gptkbp:route subcutaneous
gptkbp:safety generally safe for healthy animals
gptkbp:shelfLife 24 months
gptkbp:sideEffect mild swelling at injection site
rare serious adverse effects reported
gptkbp:storage 2-8°C
gptkbp:survivability available through veterinary clinics
gptkbp:targets gptkb:Mannheimia_haemolytica
cattle
gptkbp:training training programs for veterinarians
gptkbp:usedFor prevention_of_Mannheimia_haemolytica_infection
gptkbp:wasAffecting includes dosage and administration instructions